R ecent interest has focused on continuous measures of cardiac output and its dynamic change during positive-pressure ventilation (1, 2, 3) or passive leg raising (4) as sensitive and specific predictors of preload responsiveness. These dynamic changes can be monitored using devices that either estimate left ventricular stroke volume (LVSV) from the arterial pressure pulse (pulse contour and pulse power) (5) or descending aortic flow measured from an esophageal Doppler monitor (EDM) (6) . Although these devices have been shown to accurately reflect steady-state blood flow (5, 7, 8) , their ability to accurately measure dynamic changes in LVSV during positivepressure ventilation has never been validated. Indeed, we recently documented in a canine model that neither an arterial pulse contour device (PiCCO™ device, Pulsion Ltd.) nor an EDM device (Car-diaQ™ device, Deltex Ltd.) measured LVSV in a quantitatively similar fashion when vasomotor tone and contractility were varied by pharmacologically (9) . The arterial pulse contour SV data from that study was appropriately criticized because we used as our experimental model an acute canine preparation whose arterial compliance and impedance are markedly different from man (10) . Present pulse contour and pulse power devices use algorithms based on human vascular characteristics that can be quite different from dogs and vary differently in response to changes in sympathetic tone.
Thus, in this study we repeated our initial validation study but in humans during cardiac surgery wherein absolute aortic blood flow was measured using a calibrated electromagnetic aortic flow probe (AFP). We chose to examine the dynamic changes in LVSV induced by venous occlusion instead of positive-pressure breathing, be-cause in open-chest conditions heart-lung interactions are markedly diminished (11) . Dynamic changes in LVSV were estimated using both a pulse contour and EDM monitors. Although we initially wished to study two pulse contour devices (pulseCO™, LiDCO Ltd. and PiCCO™, Pulsion Ltd., Munich, Germany) and two EDM devices (HemoSonic™, Arrow International, Redding, PA; and CardiaQ™, Deltex Ltd., London, UK), the PiCCO device algorithm has been changed so that it now only reports mean LVSV averaged over 12 seconds and, because of technical reasons the CardiaQ™ EDM probe signal quality was unstable during open-chest conditions making its estimates of LVSV not reproducible. Thus, we chose not to study the PiCCO device and not to report on the collected CardiaQ™ EDM device data.
METHODS
The study was approved by our institutional review board for human experimentation and all patients gave informed consent for participation in the study. The goal of the study was to compare directly measured electromagnetic aortic flow-derived SV and arterial pulse pressure with estimates of LVSV and pulse pressure using arterial pulse pressure analysis and EDM as cardiac output was rap- Introduction: Measures of arterial pulse pressure variation and left ventricular stroke volume variation induced by positive-pressure breathing vary in proportion to preload responsiveness. However, the accuracy of commercially available devices to report dynamic left ventricular stroke volume variation has never been validated.
Methods: We compared the accuracy of measured arterial pulse pressure and estimated left ventricular stroke volume reported from two Food and Drug Administration-approved aortic flow monitoring devices, one using arterial pulse power (LiDCOplus™) and the other esophageal Doppler monitor (HemoSonic™). We compared estimated left ventricular stroke volume and their changes during a venous occlusion and release maneuver to a calibrated aortic flow probe placed around the aortic root on a beat-to-beat basis in seven anesthetized open-chested cardiac surgery patients.
Results: Dynamic changes in arterial pulse pressure closely tracked left ventricular stroke volume changes (mean r 2 .96). Both devices showed good agreement with steady-state apneic left ventricular stroke volume values and moderate agreement with dynamic changes in left ventricular stroke volume (esophageal Doppler monitor ؊1 ؎ 22 mL, and pulse power ؊7 ؎ 12 mL, bias ؎ 2 SD). In general, the pulse power signals tended to underestimate left ventricular stroke volume at higher left ventricular stroke volume values. Subject Recruitment. Potential subjects were identified by their primary cardiac surgeon from the regular cardiac surgical schedule. All subjects Ͼ18 yrs of age undergoing elective coronary artery bypass surgery with a left ventricular ejection fraction of Ͼ0.45 and who were at least 150 cm in height were eligible for inclusion in the study. Exclusion criteria included hemodynamic instability requiring pharmacologic support, obstructive valvulopathies, ongoing arrhythmias or the concomitant use of an artificial left ventricular assist device. Because of the highly invasive nature of this study and the potentially highrisk nature of the surgical candidates, over 47 interviews over two and a half years before 12 subjects (male/female 10/2) were recruited into the protocol. Five of the recruited subjects were withdrawn from the study before starting data collection (male/female 3/2) because of hemodynamic instability after sternotomy in preparation for cardiopulmonary bypass (three subjects) and inability to have data storage equipment available for the study (two subjects). No subject recruited in this study had any untoward events associated with the special instrumentation required in this study or the study protocol itself. Thus, we report on the studies performed in seven male subjects. Their demographics and related apneic measured hemodynamic variables are listed in Table 1 .
Instrumentation and Protocol. Anesthesia was induced and maintained at the discretion of the attending anesthesiologist. In practice this usually included using fentanyl (15-20 g/kg), with isoflurane in an air/oxygen mixture during this period of the surgery. Continuous monitoring was performed with an electrocardiogram, radial arterial pressure catheter, pulmonary arterial pressure catheter, capnography, pulse oximetry, urine output, core temperature, airway pressure, and bi-spectral electroencephalogram. In only three of the subjects because of technical reasons was the plethysmographic output of the pulse oximeter able to be recorded. Because of this large degree of missing data we chose not to report pulse oximetry plethysmographic signal data. A transesophageal echocardiographic probe (Sonos 1500 probe, Hewlett Packard Systems; Andover, MA) was then positioned and used to assess baseline cardiac performance during the initial part of the surgical procedure and also to measure the descending aortic diameter at the level of the EDM monitor. From a radial arterial catheter, pressure data were collected for off-line analysis of LVSV by the pulse power technique. Before the start of the protocol and when the patient was felt to be in stable condition the transesophageal echocardiographic probe was removed and the EDM probe inserted and calibrated, as previously described by us (6) . After sternotomy and pericardiotomy in preparation for cardiopulmonary bypass the surgeon placed a calibrated electromagnetic flow probe (Cineflo™, Carolina Medical Electronics, King, NC) around the ascending aorta, as previously described by us (11) . The integrated value of this flow signal zeroed with each diastole was taken to reflect true LVSV. The device is referred to as an AFP.
Rapid alterations of left ventricular filling were induced to produce a dynamic and adequate range of LVSV and arterial pressures to test the dynamic response of monitoring systems. The protocol consisted of a 15-sec apneic interval to define a stable steady state followed by a transient obstruction of venous return by manual compression of the right atrium until systolic arterial blood pressure decreased by approximately 20 mm Hg, referred to as venous occlusion, and then release until systolic arterial blood pressure returned to steady-state values. In practice the occlusion interval lasted from 10 to 15 seconds and release for about 5 to 10 seconds and resulted in no persistent negative cardiovascular effects or arrhythmias.
After these maneuvers, the EDM probe was removed and the transesophageal echocardiographic probe reinserted. At this time the echocardiographic probe was placed at the same location in the esophagus as the EDM probe and direct measures of the descending aortic cross-sectional diameter were made to compare with those reported by the EDM probe. The accuracy of these measures is important because as we recently documented, if the measured aortic diameter is inaccurate then estimates of changes in aortic flow will also be inaccurate (12) .
Data Collection. Arterial pressure, AFP, and EDM velocity and diameter outputs were continually recorded during each epoch of steady-state apnea and venous occlusion and release using a personal computer (Dell Pentium 300 MHz, www.dell.com). This computer collected CardiaQ, HemoSonic, AFP, and routine hemodynamic data via an A-to-D conversion system (WINDAQ v2.34, DataQ, King of Prussia, PA) at 150 Hz. The computer and A-to-D system was then used to replay the collected digitized arterial pressure waveform data from the arterial pressure output for offline calculations of LVSV via the LiDCOplus™ pulse power algorithm.
Data Analysis. The data were analyzed offline to derive individual device estimates of LVSV. The EDM descending aortic stroke volume values and its changes during the venous occlusion and release maneuver were assumed to reflect proportional changes in LVSV. Beatto-beat pulse power SV was matched to AFPderived SV measures. Paired arterial pulse pressure (diastolic to subsequent systolic pressure difference) data were also compared to SV during transient venous occlusion and release.
Statistical Analysis. Correlation between SV measures were analyzed by the Pearson moment analysis during apneic steady state, and correlation coefficient (r) and Bland-Altman analysis between AFP and measured variables during dynamic changes in LVSV, as previously described (13) 
RESULTS
All seven subjects performed at least two venous occlusion-release maneuvers, from which the one with the least EDM flow artifact was taken for analysis. If both runs were similar, the first run was used. The mean apneic hemodynamic variables for EDM and pulse power devices, including aortic diameter estimates, are summarized in Table 1 . During apneic steady-state values, both EDM and pulse power estimates of LVSV varied by Ͻ4% from measured LVSV values for all subjects. As can be seen in Figure 1 from one subject (OR8), venous occlusion resulted in marked changes in both aortic flow and arterial pressure. The relation between changes in arterial pulse pressure and LVSV measured by AFP during venous occlusion was linear across subjects ( Fig. 2 ) although the degree of correlation (R 2 ) varied from .98 to .49. The relation between pulse power estimates of LVSV and LVSV measured by AFP during venous occlusion for all subjects is shown in Figure 3 and for the EDM estimates of LVSV and LVSV measured by AFP during venous occlusion is shown in Figure 4 . In general, both devices closely tracked changes in AFPderived measures of LVSV although their absolute SV values were occasionally different, especially for the EDM data ( Fig.  4) . In one subject (OR3), the EDM data varied more than AFP-measured LVSV, but in that study LVSV changed only minimally during venous occlusion. On inspection of OR3 raw flow signals, un-like the other six subjects, we identified a shifting AFP baseline during the venous obstruction maneuver making estimates of LVSV from the device's algorithm inaccurate. Another venous occlusion maneuver without such baseline shifts was available for the pulse power analysis for that subject. The difference between transesophageal echocardiographic and EDM estimates aortic cross-sectional diameter were minimal (Table 1) . Although individual subject's pulse power and EDM estimates of SV tended to track dynamic changes in LVSV as measured by the AFP, pooled data for both methods were less robust, suggesting that dynamic changes in estimated LVSV need to be limited to the same subject and not to pooled data. Importantly, the dynamic changes shown in Figures 3 and 4 for individual subjects did not have similar precision or bias when pooled for the Bland-Altman analyses (Figs. 5 and 6) for pulse contour and EDM, respectively. Both devices displayed a good degree of precision across the LVSV range, but also displayed a significant and unpredictable bias. This bias persisted when apneic steady-state LVSV values were also compared ( Table 1) .
DISCUSSION
This study quantifies the accuracy of both arterial pulse power and EDM devices to assess steady-state LVSV and its dynamic changes as LVSV is rapidly varied by venous occlusion and release in humans. Not surprisingly, arterial pulse pressure changes were coupled to LVSV changes. These data underscore the use of pulse pressure variation as a surrogate of LVSV variation in clinical trials. Furthermore, both the pulse power and the EDM methods, when displaying good quality signals, assessed to a good degree of accuracy in estimating LVSV (Table 1) . Because both pulse power and EDM steady-state measures tracked steadystate LVSV, both can also be used to report the dynamic changes in mean aortic flow during passive leg raising that require measures averaged over 20 seconds (4, 6) . However, the ability of either device to assess dynamic change in LVSV was only good for the pulse contour method and less so for the EDM.
The individual subject analysis shown of the pulse power device (Fig. 5) shows that it faithfully reports AFP-derived LVSV measures at lower LVSV values, but tends to under-estimate LVSV at higher LVSV val-ues. Qualitatively similar but directionally opposite changes are seen with the EDM device ( Fig. 6) . Thus, both pulse power and EDM values can be used clinically as surrogate measures of steady-state SV, but only arterial pulse pressure and pulse power closely track LVSV under conditions of rapidly changing LVSV conditions. At lower LVSV values (i.e., LVSV Ͻ65 mL), pulse power accurately estimates absolute dynamic changes in LVSV as well. Importantly, DeCastro et al. (14) estimated the variance of individual subjects LVSV using transesophageal Doppler and compared it to simultaneously measured LVSV by the PiCCO device pulse contour technique in 20 patients undergoing aortic surgery. They too found that mean LVSV values agreed between the devices but that LVSV variation measures had 10% variance, making its ability to tract small changes in LVSV variation marginal. These variances are similar to those we and others reported for the same PiCCO device in animal studies (9, 15) . Because the LiDCO and PiCCO devices use different qualities of the arterial pressure pulse to calculate LVSV, these qualitative differences between the Bland-Altman analysis for LiDCO™ and PiCCO™ may reflect fundamental differences in their calculation algorithms. Thus, clinical validation studies need to be device-specific if they are to be used to validate the accuracy of a 
